Neurobiological acquires Empire Technologies

NTII acquired Empire (Greenville, N.Y.) for cash and stock. The deal gives NTII rights to Empire's Viprinex ancrod, a perfusion therapy to treat acute ischemic stroke. NTII issued 2.4 million shares a...